Palisade Bio's three largest insider shareholders as of May 14, 2026 are Thomas Hallam (Chief Executive Officer, 57.59K shares), John David Finley (Chief Financial Officer, 38.87K shares), Donald Allen Williams (Director, 30.00K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Thomas Hallam | Chief Executive Officer | 57,592 | 0 | 18 Aug, 2022 |
| John David Finley | Chief Financial Officer | 0 | 38,867 | 02 May, 2022 |
| Donald Allen Williams | - | 0 | 30,000 | 01 Feb, 2024 |
| John David Finley | Ceo, Cfo | 27,353 | 0 | 13 Feb, 2026 |
| Thomas Hallam | Chief Executive Officer | 17,592 | 0 | 28 Mar, 2022 |
| Michael John Dawson | Chief Medical Officer | 15,000 | 0 | 30 Mar, 2022 |
| Robert J. Trenschel | - | 14,999 | 0 | 13 Sep, 2021 |
| John David Finley | Ceo, Cfo, Director | 13,472 | 0 | 30 May, 2024 |
| Mitchell Lawrence Jones | Chief Medical Officer | 13,263 | 0 | 13 Feb, 2026 |
| Cristina Csimma | - | 12,862 | 0 | 13 Feb, 2024 |
| Stephanie Diaz | - | 12,800 | 0 | 13 Feb, 2024 |
| James R Neal | - | 10,920 | 0 | 13 Feb, 2024 |
| Robert J. Trenschel | - | 10,920 | 0 | 13 Feb, 2024 |
| Donald Allen Williams | - | 10,728 | 0 | 21 Jan, 2026 |
| Mitchell Lawrence Jones | Chief Medical Officer | 3,852 | 0 | 30 May, 2024 |
| Binxian Wei | - | 855 | 0 | 22 Nov, 2024 |
| Donald Allen Williams | - | 728 | 0 | 22 Nov, 2024 |
| Robert Curtis Mcrae | Chief Operating Officer | 625 | 0 | 05 Apr, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Feb, 2026 | Mitchell Lawrence Jones | Common Stock | A | 8,000 | - | 15,252 | D | M |
| 11 Feb, 2026 | John David Finley | Common Stock | A | 13,333 | - | 31,249 | D | M |
| 12 Feb, 2026 | Mitchell Lawrence Jones | Common Stock | D | 1,989 | $1.75 | 13,263 | D | S |
| 12 Feb, 2026 | John David Finley | Common Stock | D | 3,896 | $1.75 | 27,353 | D | S |
| 11 Feb, 2026 | Mitchell Lawrence Jones | Restricted Stock Units | D | 8,000 | $0.00 | 16,000 | D | M |
| 11 Feb, 2026 | John David Finley | Restricted Stock Units | D | 13,333 | $0.00 | 26,667 | D | M |
| 09 Feb, 2026 | John David Finley | Restricted Stock Units | A | 2,011,000 | $0.00 | 2,011,000 | D | A |
| 09 Feb, 2026 | Mitchell Lawrence Jones | Restricted Stock Units | A | 787,000 | $0.00 | 787,000 | D | A |
| 16 Jan, 2026 | Donald Allen Williams | Common Stock | A | 5,000 | $1.67 | 10,728 | D | P |
| 09 Jan, 2026 | Donald Allen Williams | Common Stock | A | 5,000 | $1.88 | 5,728 | D | P |
| 06 Oct, 2025 | Emil Chuang | Restricted Stock Units | A | 60,600 | $0.00 | 60,600 | D | A |
| 06 Oct, 2025 | Binxian Wei | Restricted Stock Units | A | 60,600 | $0.00 | 60,600 | D | A |
| 06 Oct, 2025 | Donald Allen Williams | Restricted Stock Units | A | 182,000 | $0.00 | 182,000 | D | A |
| 06 Oct, 2025 | Donald Allen Williams | Restricted Stock Units | A | 1,538,700 | $0.00 | 1,538,700 | D | A |
| 06 Oct, 2025 | Binxian Wei | Restricted Stock Units | A | 510,700 | $0.00 | 510,700 | D | A |
| 06 Oct, 2025 | Mitchell Lawrence Jones | Restricted Stock Units | A | 7,665,800 | $0.00 | 7,665,800 | D | A |
| 06 Oct, 2025 | Emil Chuang | Restricted Stock Units | A | 510,700 | $0.00 | 510,700 | D | A |
| 06 Oct, 2025 | John David Finley | Restricted Stock Units | A | 9,179,400 | $0.00 | 9,179,400 | D | A |
| 04 Sep, 2025 | Donald Allen Williams | Phantom Units | A | 64,400 | $0.00 | 64,400 | D | A |
| 04 Sep, 2025 | Binxian Wei | Phantom Units | A | 18,800 | $0.00 | 18,800 | D | A |